Vlachoyiannopoulos PG - Search Results

1

Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.

Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM. Tektonidou MG, et al. Among authors: vlachoyiannopoulos pg. Arthritis Rheum. 2004 Aug;50(8):2569-79. doi: 10.1002/art.20433. Arthritis Rheum. 2004. PMID: 15334471 Free article.

2

Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.

Pakas I, Ioannidis JP, Malagari K, Skopouli FN, Moutsopoulos HM, Vlachoyiannopoulos PG. Pakas I, et al. Among authors: vlachoyiannopoulos pg. J Rheumatol. 2002 Feb;29(2):298-304. J Rheumatol. 2002. PMID: 11842824 Clinical Trial.

3

Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging.

Tektonidou MG, Malagari K, Vlachoyiannopoulos PG, Kelekis DA, Moutsopoulos HM. Tektonidou MG, et al. Among authors: vlachoyiannopoulos pg. Arthritis Rheum. 2003 Mar;48(3):732-6. doi: 10.1002/art.10835. Arthritis Rheum. 2003. PMID: 12632427 Free article.

4

Antiphospholipid syndrome triggered by thalidomide in a patient with discoid lupus erythematosus.

Tektonidou MG, Vlachoyiannopoulos PG. Tektonidou MG, et al. Among authors: vlachoyiannopoulos pg. Lupus. 2003;12(9):723-4. doi: 10.1191/0961203303lu427xx. Lupus. 2003. PMID: 14514139 No abstract available.

5

Peripheral vascular disease in antiphospholipid syndrome.

Vlachoyiannopoulos PG, Samarkos M. Vlachoyiannopoulos PG, et al. Thromb Res. 2004;114(5-6):509-19. doi: 10.1016/j.thromres.2004.06.027. Thromb Res. 2004. PMID: 15507285 Review.

6

Anti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythematosus.

Vlachoyiannopoulos PG, Mavragani CP, Bourazopoulou E, Balitsari AV, Routsias JG. Vlachoyiannopoulos PG, et al. Thromb Haemost. 2004 Dec;92(6):1303-11. doi: 10.1160/TH04-02-0135. Thromb Haemost. 2004. PMID: 15583738

7

Mortality in systemic sclerosis: an international meta-analysis of individual patient data.

Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, Kuwana M, Yasuoka H, van den Hoogen F, Te Boome L, van Laar JM, Verbeet NL, Matucci-Cerinic M, Georgountzos A, Moutsopoulos HM. Ioannidis JP, et al. Among authors: vlachoyiannopoulos pg. Am J Med. 2005 Jan;118(1):2-10. doi: 10.1016/j.amjmed.2004.04.031. Am J Med. 2005. PMID: 15639201

8

Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline.

Plastiras SC, Karadimitrakis SP, Ziakas PD, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzelepis GE. Plastiras SC, et al. Among authors: vlachoyiannopoulos pg. Arthritis Rheum. 2006 Aug 15;55(4):598-602. doi: 10.1002/art.22099. Arthritis Rheum. 2006. PMID: 16874782 Free article.

9

Glucocorticoid receptor, nuclear factor kappaB, activator protein-1 and C-jun N-terminal kinase in systemic lupus erythematosus patients.

Oikonomidou O, Vlachoyiannopoulos PG, Kominakis A, Kalofoutis A, Moutsopoulos HM, Moutsatsou P. Oikonomidou O, et al. Among authors: vlachoyiannopoulos pg. Neuroimmunomodulation. 2006;13(4):194-204. doi: 10.1159/000100474. Epub 2007 Mar 7. Neuroimmunomodulation. 2006. PMID: 17347585

10

Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.

Vlachoyiannopoulos PG, Toya SP, Katsifis G, Zintzaras E, Tzioufas AG, Moutsopoulos HM. Vlachoyiannopoulos PG, et al. J Rheumatol. 2008 Sep;35(9):1768-75. Epub 2008 Jul 15. J Rheumatol. 2008. PMID: 18634157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters